Survival, the IISS’s bimonthly journal, challenges conventional wisdom and brings fresh, often controversial, perspectives on strategic issues of the moment. In this issue: Franz-Stefan Gady and Michael Kofman highlight the pitfalls of grafting a Western manoeuvre-oriented approach to war onto the Russia–Ukraine conflict Irene Mia examines the chasm between Javier Milei’s dramatic rhetoric and the domestic and international obstacles he faces to changing Argentina’s foreign and economic policies Edoardo Campanella and John Haigh outline the necessity of meaningful dialogue between the West and China to prevent the internet’s fragmentation John Raine assesses the geopolitical trends that the Gaza war has set in motion and the issues they create for Ukraine’s defence against Russia And seven more thought-provoking pieces, as well as our regular Book Reviews and Noteworthy column. Editor: Dr Dana Allin Managing Editor: Jonathan Stevenson Associate Editor: Carolyn West Editorial Assistant: Conor Hodges

Survival, the IISS's bimonthly journal, challenges conventional wisdom and brings fresh, often controversial, perspectives on strategic issues of the moment. In this issue: Franz-Stefan Gady and Michael Kofman highlight the pitfalls of grafting a Western manoeuvre-oriented approach to war onto the Russia-Ukraine conflict Irene Mia examines the chasm between Javier Milei's dramatic rhetoric and the domestic and international obstacles he faces to changing Argentina's foreign and economic policies Edoardo Campanella and John Haigh outline the necessity of meaningful dialogue between the West and China to prevent the internet's fragmentation John Raine assesses the geopolitical trends that the Gaza war has set in motion and the issues they create for Ukraine's defence against Russia And seven more thought-provoking pieces, as well as our regular Book Reviews and Noteworthy column. Editor: Dr Dana Allin Managing Editor: Jonathan Stevenson Associate Editor: Carolyn West Editorial Assistant: Conor Hodges

Published each year since 1959, The Military Balance is an indispensable reference to the capabilities of armed forces across the globe. It is used by academia, the media, armed forces, the private sector and government. It is an open-source assessment of the military forces and equipment inventories of 171 countries, with accompanying defence economics and procurement data. Alongside detailed country data, The Military Balance assesses important defence issues, by region, as well as key global trends, such as in defence technology and equipment modernisation. This analysis is accompanied by full-colour graphics, including maps and illustrations. With extensive explanatory notes and reference information, The Military Balance is as straightforward to use as it is extensive. The 2022 edition is accompanied by a fullcolour wall chart illustrating security dynamics in the Arctic.

Owing to the availability of more advanced genetically engineered pigs, more immunological and physiological barriers have been overcome. With the results of pig organ xenotransplantation steadily improving, consideration is now given to the first clinical trials of xenotransplantation. The first step is kidneys, but possibilities also exist in pig islet transplantation for patients with diabetes.

Gliomas are neoplasms originating in glial cells, the most malignant and frequent primary tumors of the Central Nervous System (CNS), representing approximately 40-50% of all intracranial tumors. Following the World Health Organization (WHO) guidelines, gliomas are classified into grades I-IV, regarding their malignancy degree. The latest report from WHO on CNS tumors considers that glioblastoma (GB), a grade IV adult-type diffuse glioma comprising isocitrate dehydrogenase (IDH)-wildtype tumors. Despite all efforts to improve patient survival and quality of life, the median survival remains lower due to the lack of effective diagnostic tools, poor prognosis, and limited therapeutic options. Regarding this, the design of novel treatment strategies is of the utmost importance. This can be by either the discovery of new medicines (for example synthetic compounds), repurposing known drugs or exploring novel strategies of drug delivery by nanotechnological platforms to improve treatment response and long-term survival of patients. Inter and intra-tumor heterogeneity mainly contribute to the poor prognosis and treatment efficacy. Therefore, exploiting tumor microenvironment (TME) and understanding GB’s cellular and molecular aspects are fundamental to developing more effective and better-tolerated personalized therapies. Thus, addressing physiological mechanisms involved in cancer development, progression and recurrence is crucial. Concerning this, our goal with this research topic is to share the latest advances in tumor-specific therapies for gliomas, especially GB, as well as to provide experimental validation of new bioactive molecules and their antitumor mechanism of action. Authors are invited to submit original research, review articles and systematic reviews covering, but not restricted to, the following topics: 1) Novel targeted therapies; 2) Mechanism of action and affected signaling pathways; 3) Repurposing drugs; 5) New chemical entities; 6) Pharmaceutical nanotechnology; 7) Drug delivery systems; 8) Preclinical and clinical studies of therapeutic molecules; 9) Potential molecular biomarkers to targeted therapies using proteomics or transcriptomics.

The miraculous account of the man who survived alone and adrift at sea longer than anyone in recorded history. For fourteen months, Alvarenga survived constant shark attacks. He learned to catch fish with his bare hands. He built a fish net from a pair of empty plastic bottles. Taking apart the outboard motor, he fashioned a huge fishhook. Using fish vertebrae as needles, he stitched together his own clothes. Based on dozens of hours of interviews with Alvarenga and interviews with his colleagues, search and rescue officials, the medical team that saved his life and the remote islanders who nursed him back to health, this is an epic tale of survival. Print run 75,000.